- Home
- MQ vs BCRX Comparison
MQ vs BCRX Comparison
Compare MQ & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MQ | BCRX |
|---|---|---|
| Founded | 2010 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MQ | BCRX |
|---|---|---|
| Price | $4.02 | $8.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | $5.36 | ★ $20.82 |
| AVG Volume (30 Days) | ★ 4.6M | 4.0M |
| Earning Date | 05-25-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | ★ $624,884,000.00 | $25,186,000.00 |
| Revenue This Year | $17.47 | N/A |
| Revenue Next Year | $16.47 | $12.55 |
| P/E Ratio | ★ N/A | $7.00 |
| Revenue Growth | ★ 23.25 | N/A |
| 52 Week Low | $3.48 | $6.00 |
| 52 Week High | $7.04 | $11.31 |
Technical Indicators
Market Signals| Indicator | MQ | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 69.72 |
| Support Level | $3.80 | $7.95 |
| Resistance Level | $4.46 | $8.68 |
| Average True Range (ATR) | 0.19 | 0.33 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 54.46 | 81.19 |
Price Performance
Historical ComparisonAbout MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.